<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:ns2="http://www.sec.gov/edgar/common">
    <headerData>
        <submissionType>144</submissionType>
        <filerInfo>
            <filer>
                <filerCredentials>
                    <cik>0001673232</cik>
                    <ccc>XXXXXXXX</ccc>
                </filerCredentials>
            </filer>
            <liveTestFlag>LIVE</liveTestFlag>



        </filerInfo>
    </headerData>
    <formData>
        <issuerInfo>
            <issuerCik>0001082554</issuerCik>
            <issuerName>United Therapeutics Corporation</issuerName>
            <secFileNumber>000-26301</secFileNumber>
            <issuerAddress>
                <ns2:street1>1000 SPRING ST</ns2:street1>
                <ns2:city>SILVER SPRING</ns2:city>
                <ns2:stateOrCountry>MD</ns2:stateOrCountry>
                <ns2:zipCode>20910</ns2:zipCode>
            </issuerAddress>
            <issuerContactPhone>(301)608-9292</issuerContactPhone>
            <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Michael Benkowitz</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
            <relationshipsToIssuer>
                <relationshipToIssuer>Officer</relationshipToIssuer>
            </relationshipsToIssuer>
        </issuerInfo>
        <securitiesInformation>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <brokerOrMarketmakerDetails>
                <name>Morgan Stanley Smith Barney LLC Executive Financial Services</name>
                <address>
                    <ns2:street1>1 New York Plaza</ns2:street1>
                    <ns2:street2>8th Floor</ns2:street2>
                    <ns2:city>New York</ns2:city>
                    <ns2:stateOrCountry>NY</ns2:stateOrCountry>
                    <ns2:zipCode>10004</ns2:zipCode>
                </address>
            </brokerOrMarketmakerDetails>
            <noOfUnitsSold>40000</noOfUnitsSold>
            <aggregateMarketValue>15310800.00</aggregateMarketValue>
            <noOfUnitsOutstanding>44644519</noOfUnitsOutstanding>
            <approxSaleDate>11/06/2024</approxSaleDate>
            <securitiesExchangeName>NASDAQ</securitiesExchangeName>
        </securitiesInformation>
        <securitiesToBeSold>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <acquiredDate>11/06/2024</acquiredDate>
            <natureOfAcquisitionTransaction>Exercise of Stock Options</natureOfAcquisitionTransaction>
            <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
            <isGiftTransaction>N</isGiftTransaction>
            <amountOfSecuritiesAcquired>40000</amountOfSecuritiesAcquired>
            <paymentDate>11/06/2024</paymentDate>
            <natureOfPayment>Cash</natureOfPayment>
        </securitiesToBeSold>
        <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>Michael Benkowitz</name>
                <address>
                    <ns2:street1>1000 SPRING ST</ns2:street1>
                    <ns2:city>SILVER SPRING</ns2:city>
                    <ns2:stateOrCountry>MD</ns2:stateOrCountry>
                    <ns2:zipCode>20910</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>11/01/2024</saleDate>
            <amountOfSecuritiesSold>14700</amountOfSecuritiesSold>
            <grossProceeds>5504562.00</grossProceeds>
        </securitiesSoldInPast3Months>
        <securitiesSoldInPast3Months>
            <sellerDetails>
                <name>Michael Benkowitz</name>
                <address>
                    <ns2:street1>1000 SPRING ST</ns2:street1>
                    <ns2:city>SILVER SPRING</ns2:city>
                    <ns2:stateOrCountry>MD</ns2:stateOrCountry>
                    <ns2:zipCode>20910</ns2:zipCode>
                </address>
            </sellerDetails>
            <securitiesClassTitle>Common</securitiesClassTitle>
            <saleDate>08/07/2024</saleDate>
            <amountOfSecuritiesSold>25000</amountOfSecuritiesSold>
            <grossProceeds>8084500.00</grossProceeds>
        </securitiesSoldInPast3Months>
        <remarks>Shares sold by the Michael I. Benkowitz Revocable Trust and the Benkowitz Descendants GST Exempt Trust, which are each beneficially owned by Michael Benkowitz, who is an officer of the issuer. </remarks>
        <noticeSignature>
            <noticeDate>11/06/2024</noticeDate>
            <planAdoptionDates>
                <planAdoptionDate>08/07/2024</planAdoptionDate>
            </planAdoptionDates>
            <signature>/s/ Michael Benkowitz</signature>
        </noticeSignature>
    </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4940}]
144
0001673232
XXXXXXXX
LIVE
0001082554
United Therapeutics Corporation
000-26301
1000 SPRING ST
SILVER SPRING
MD
20910
(301)608-9292
Michael Benkowitz
Officer
Common
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
40000
15310800.00
44644519
11/06/2024
NASDAQ
Common
11/06/2024
Exercise of Stock Options
Issuer
N
40000
11/06/2024
Cash
N
Michael Benkowitz
1000 SPRING ST
SILVER SPRING
MD
20910
Common
11/01/2024
14700
5504562.00
Michael Benkowitz
1000 SPRING ST
SILVER SPRING
MD
20910
Common
08/07/2024
25000
8084500.00
Shares sold by the Michael I. Benkowitz Revocable Trust and the Benkowitz Descendants GST Exempt Trust, which are each beneficially owned by Michael Benkowitz, who is an officer of the issuer.
11/06/2024
08/07/2024
/s/ Michael Benkowitz